Aidoc vs SigTuple
In-depth comparison — valuation, funding, investors, founders & more
🇮🇱 Israel · Elad Walach
Valuation
N/A
Total Funding
$370M
300 employees
🇮🇳 India · Rohit Kumar Pandey
Valuation
N/A
Total Funding
$20M
100-500 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Aidoc and SigTuple compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging. SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists.
Neither company has publicly disclosed a valuation at this time. On the funding side, Aidoc has raised $370M in total — $350M more than SigTuple's $20M.
SigTuple has 1 year more market experience, having been founded in 2015 compared to Aidoc's 2016 founding. In terms of growth stage, Aidoc is at Series D while SigTuple is at Series B — a meaningful difference for investors evaluating risk and upside.
Aidoc operates out of 🇮🇱 Israel while SigTuple is based in 🇮🇳 India, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Aidoc leads with a score of 67, reflecting stronger overall fundamentals across valuation, funding, and growth signals.
Metrics Comparison
| Metric | Aidoc | SigTuple |
|---|---|---|
💰Valuation | N/A | N/A |
📈Total Funding | $370MWINS | $20M |
📅Founded | 2016WINS | 2015 |
🚀Stage | Series D | Series B |
👥Employees | 300 | 100-500 |
🌍Country | Israel | India |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 67WINS | 60 |
Key Differences
Funding gap: Aidoc has raised $350M more ($370M vs $20M)
Market experience: SigTuple has 1 year more (founded 2015 vs 2016)
Growth stage: Aidoc is at Series D vs SigTuple at Series B
Team size: Aidoc has 300 employees vs SigTuple's 100-500
Market base: 🇮🇱 Aidoc (Israel) vs 🇮🇳 SigTuple (India)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Aidoc scores 67/100 vs SigTuple's 60/100
Which Should You Choose?
Use these signals to make the right call
Choose Aidoc if…
Top Pick- ✓Higher Awaira Score — 67/100 vs 60/100
- ✓Stronger investor backing — raised $370M
- ✓Israel-based for regional compliance or proximity
- ✓Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging
Choose SigTuple if…
- ✓More market experience — founded in 2015
- ✓India-based for regional compliance or proximity
- ✓SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists
Funding History
Aidoc raised $370M across 8 rounds. SigTuple raised $20M across 0 rounds.
Aidoc
Series D
Dec 2021
Lead: Insight Partners
Series D
Jun 2021
Lead: Macquarie Group
Series C
Sep 2020
Lead: Khosla Ventures
Series C
Sep 2020
Lead: Ibex Investors
Series B
Jan 2019
Lead: GE Ventures
Series B
Jan 2019
Lead: Khosla Ventures
Series A
Jan 2018
Series A
Jan 2018
Lead: Pitango VC
SigTuple
No public funding data available.
Investor Comparison
No shared investors detected between these two companies.
Unique to Aidoc